MLXIPL and liver disorder: These previous studies from our laboratory and others suggest context-specific roles of hepatic ChREBP in advanced liver disease, in particular hepatocellular tumour susceptibility, which are of critical importance to establish the therapeutic potential of ChREBP for the treatment of liver disease in GSD Ia patients.